A randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy
| ISRCTN | ISRCTN48733595 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN48733595 |
| Protocol serial number | Breast Dosimetry |
| Sponsor | Cancer Research UK (CRUK) (UK) |
| Funders | Cancer Research UK, Institute of Cancer Research, Royal Marsden Hospital , South East Thames Regional Health Authority |
- Submission date
- 15/10/2002
- Registration date
- 15/10/2002
- Last edited
- 08/04/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
- -
Scientific
Scientific
UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | A randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Breast cancer |
| Intervention | 1. Radiotherapy with either custom-made compensators 2. Standard wedge compensators |
| Intervention type | Other |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 19/01/2000 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Female |
| Key inclusion criteria | 1. Early breast cancer (T1-3a N0-1 M0) 2. Histological confirmation of invasive carcinoma 3. Breast-preserving surgery 4. Higher than average risk of radiation normal tissue changes due to large breast size or irregular breast shape 5. Radiotherapy to the breast +/- lymphatics 6. No previous malignancy 7. Written informed consent |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/1997 |
| Date of final enrolment | 19/01/2000 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom
NW1 2DA
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | |
| IPD sharing plan |
